Helix Acquisition Corp. III Prices IPO at $10.00 per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 23 2026
0mins
Should l Buy HLXC?
Helix Acquisition Corp. III priced its upsized initial public offering of 15,000,000 Class A ordinary shares at $10.00 per share. The shares will be listed on The Nasdaq Global Market and trade under the ticker symbol "HLXC". The Company expects the offering to be consummated on January 26. The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on opportunities in healthcare or healthcare-related industries. The Company, sponsored by Helix Holdings III, an affiliate of Cormorant Asset Management, is led by Bihua Chen as CEO and Chairperson, and Caleb Tripp as CFO and COO. Leerink Partners and Oppenheimer & Co. are serving as the joint bookrunning managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 Class A ordinary shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HLXC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HLXC
About HLXC
Helix Acquisition Corp III located in Boston, Massachusetts is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
BitGo Prices IPO at $213 Million, EquipmentShare Raises $747 Million with 33% First Day Surge
- BitGo IPO Performance: BitGo priced its US IPO at $213 million, achieving a market cap of $2.2 billion, and despite an initial 25% gain, the stock closed 19% below the offer price, indicating market caution towards digital asset infrastructure.
- EquipmentShare.com Success: EquipmentShare.com raised $747 million with a market cap of $6.7 billion, and its shares surged 33% on the first day, reflecting strong demand in the construction equipment rental market and the effectiveness of its digital platform.
- SPAC Market Activity: Six SPACs went public this week, with Helix Acquisition III and Archimedes Tech SPAC Partners III upsizing their offerings, demonstrating ongoing investor interest in healthcare and technology sectors.
- IPO Market Overview: As of January 22, 2026, the Renaissance IPO Index has risen 3.8% year-to-date, outperforming the S&P 500's 1.1% increase, highlighting the strong performance of newly public companies relative to the broader market.
See More
Helix Acquisition (HLXC) Prices Upsized IPO at $10, Expected to Close on January 26, 2026
- IPO Pricing: Helix Acquisition has priced its upsized initial public offering of 15 million Class A ordinary shares at $10 per share, indicating strong market confidence and potentially raising $150 million to support future growth initiatives.
- Underwriter Option: The company has granted underwriters a 45-day option to purchase an additional 2.25 million Class A ordinary shares at the IPO price, which could further enhance its capital structure and market appeal.
- Funding Timeline: The IPO is expected to close on January 26, 2026, marking a significant milestone for the company in the capital markets and helping to elevate its brand visibility and competitive positioning.
- Market Reaction Anticipation: As the IPO progresses, Helix Acquisition is likely to attract investor interest, strengthening its industry position and laying a financial foundation for subsequent strategic expansions.
See More
Helix Acquisition III Raises $150 Million, Targets Healthcare Sector
- Increased Fundraising: Helix Acquisition III successfully raised $150 million by offering 15 million shares, exceeding its original target of $125 million, indicating strong market interest in the healthcare sector.
- Unique Structure Design: Unlike most SPACs, the company did not offer units with warrants or rights attached, potentially attracting investors seeking a simplified investment structure, thereby enhancing its market competitiveness.
- Strong Management Background: Led by CEO Bihua Chen, founder and Managing Member of Cormorant Asset Management, and CFO Caleb Tripp, who also hails from the firm, the team's expertise provides robust support for its healthcare investment strategy.
- Clear Market Focus: Helix Acquisition III plans to target healthcare-related industries, particularly in biotech, medtech, and life sciences, aiming to leverage its management's extensive experience in healthcare investments to drive future growth.
See More
Helix Acquisition Corp. III Prices $150 Million IPO
- IPO Pricing: Helix Acquisition Corp. III has priced its initial public offering of 15 million Class A ordinary shares at $10 per share, successfully raising $150 million to fund future business combinations.
- Exchange Listing: The offering is expected to close on January 26, with shares set to begin trading on the Nasdaq Global Market under the ticker symbol 'HLXC', marking the company's official entry into the capital markets.
- Over-Allotment Option: Underwriters have been granted a 45-day option to purchase an additional 2.25 million Class A ordinary shares to cover over-allotments, which will enhance the company's financial flexibility.
- Industry Focus: As a special purpose acquisition company, Helix Acquisition Corp. III is focused on pursuing business combinations in the healthcare or healthcare-related industries, indicating its strategic positioning in the rapidly evolving healthcare market.
See More
BitGo Prices IPO at $213 Million, EquipmentShare Raises $747 Million with 33% First Day Surge
- BitGo IPO Performance: BitGo priced its US IPO at $213 million, achieving a market cap of $2.2 billion, and despite an initial 25% gain, the stock closed 19% below the offer price, indicating market caution towards digital asset infrastructure.
- EquipmentShare.com Success: EquipmentShare.com raised $747 million with a market cap of $6.7 billion, and its shares surged 33% on the first day, reflecting strong demand in the construction equipment rental market and the effectiveness of its digital platform.
- SPAC Market Activity: Six SPACs went public this week, with Helix Acquisition III and Archimedes Tech SPAC Partners III upsizing their offerings, demonstrating ongoing investor interest in healthcare and technology sectors.
- IPO Market Overview: As of January 22, 2026, the Renaissance IPO Index has risen 3.8% year-to-date, outperforming the S&P 500's 1.1% increase, highlighting the strong performance of newly public companies relative to the broader market.
See More
Helix Acquisition (HLXC) Prices Upsized IPO at $10, Expected to Close on January 26, 2026
- IPO Pricing: Helix Acquisition has priced its upsized initial public offering of 15 million Class A ordinary shares at $10 per share, indicating strong market confidence and potentially raising $150 million to support future growth initiatives.
- Underwriter Option: The company has granted underwriters a 45-day option to purchase an additional 2.25 million Class A ordinary shares at the IPO price, which could further enhance its capital structure and market appeal.
- Funding Timeline: The IPO is expected to close on January 26, 2026, marking a significant milestone for the company in the capital markets and helping to elevate its brand visibility and competitive positioning.
- Market Reaction Anticipation: As the IPO progresses, Helix Acquisition is likely to attract investor interest, strengthening its industry position and laying a financial foundation for subsequent strategic expansions.
See More
Helix Acquisition III Raises $150 Million, Targets Healthcare Sector
- Increased Fundraising: Helix Acquisition III successfully raised $150 million by offering 15 million shares, exceeding its original target of $125 million, indicating strong market interest in the healthcare sector.
- Unique Structure Design: Unlike most SPACs, the company did not offer units with warrants or rights attached, potentially attracting investors seeking a simplified investment structure, thereby enhancing its market competitiveness.
- Strong Management Background: Led by CEO Bihua Chen, founder and Managing Member of Cormorant Asset Management, and CFO Caleb Tripp, who also hails from the firm, the team's expertise provides robust support for its healthcare investment strategy.
- Clear Market Focus: Helix Acquisition III plans to target healthcare-related industries, particularly in biotech, medtech, and life sciences, aiming to leverage its management's extensive experience in healthcare investments to drive future growth.
See More
Helix Acquisition Corp. III Prices $150 Million IPO
- IPO Pricing: Helix Acquisition Corp. III has priced its initial public offering of 15 million Class A ordinary shares at $10 per share, successfully raising $150 million to fund future business combinations.
- Exchange Listing: The offering is expected to close on January 26, with shares set to begin trading on the Nasdaq Global Market under the ticker symbol 'HLXC', marking the company's official entry into the capital markets.
- Over-Allotment Option: Underwriters have been granted a 45-day option to purchase an additional 2.25 million Class A ordinary shares to cover over-allotments, which will enhance the company's financial flexibility.
- Industry Focus: As a special purpose acquisition company, Helix Acquisition Corp. III is focused on pursuing business combinations in the healthcare or healthcare-related industries, indicating its strategic positioning in the rapidly evolving healthcare market.
See More
